Videos

Videos

Tardive Dyskinesia: Impacts, Assessment, and Treatment Options

04/15/2024

Featuring Desiree Matthews, PMHNP-BC

Featuring Desiree Matthews, PMHNP-BC ...

Gain fresh insights into the multifaceted impacts of tardive dyskinesia (TD) with Desiree Matthews, PMHNP-BC, as she explores the physical, social, and emotional consequences faced by patients living with TD.

Gain fresh insights into the...

04/15/2024

Psych Congress Network

Western AF 2024 Interview

What It Takes to Move Atrial Fibrillation Practice to the Outpatient Setting

04/15/2024

Interview by Jodie Elrod

In this interview from Western AF 2024, we speak with Suneet Mittal, MD, from the Valley Health System on what it takes to move atrial fibrillation (AF) practice to the outpatient setting.

In this interview from Western...

04/15/2024

EP Lab Digest

Western AF 2024 Interview

The New Atrial Fibrillation Guidelines

04/15/2024

Interview by Jodie Elrod

In this interview from Western AF 2024, we speak with Mina Chung, MD, from the Cleveland Clinic about the 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation (AF).

In this interview from Western...

04/15/2024

EP Lab Digest

Western AF 2024 Interview

Updates in Pulsed Field Ablation for the Treatment of Atrial Fibrillation, Including Safety, Efficacy, and Future Directions

04/14/2024

Interview by Jodie Elrod

In this interview from Western AF 2024, we speak with Amin Al-Ahmad, MD, from Texas Cardiac Arrhythmia in Austin, Texas, about updates in pulsed field ablation (PFA) for the treatment of atrial fibrillation (AF).

In this interview from Western...

04/14/2024

EP Lab Digest

Chest Pain in women

Horses and Zebras: Multimodality Imaging in the Evaluation of Chest Pain in Women

04/12/2024

Emily S. Lau, MD, MPH, FACC

Director, Cardiometabolic Health & Hormones Clinic; Corrigan Women’s Heart Health Program, Massachusetts General Hospital; Assistant Professor of Medicine, Harvard Medical School, Boston, Massachusetts

@emilyswlau

Emily S. Lau, MD, MPH, FACC Director...

"Even in 2024, we are continuing to see pretty striking gender disparities in health outcomes between men and women, especially with ischemic heart disease," says Dr. Lau. "And there remains, I think, still a lack of understanding or...

"Even in 2024, we are continuing...

04/12/2024

Cath Lab Digest

Videos

Y90 Radioembolization for Patients With Hepatocellular Carcinoma Who Have Undergone Prior Resection

04/12/2024

Featuring Daniel B. Brown, MD, FSIR

Featuring Daniel B. Brown, MD, FSIR ...

Daniel B. Brown, MD, FSIR, shares insights on an analysis of the RESiN study, evaluating the use of Y90 radioembolization for patients with hepatocellular carcinoma who had undergone previous resection.

Daniel B. Brown, MD, FSIR,...

04/12/2024

IO Learning

Conference Coverage

Stefan Holubar, MD, on Perianal Crohn's Disease

04/12/2024

Dr Holubar reviews medical and surgical options for treating perianal Crohn's disease.

Dr Holubar reviews medical and...

04/12/2024

Advances in Inflammatory Bowel Disease Network

Conference Coverage

Jean Ashburn, MD, on Perioperative Complications in IBD

04/12/2024

Dr Jean Ashburn discusses the complications that can occur around the time of surgery among patients with inflammatory bowel disease.

Dr Jean Ashburn discusses the...

04/12/2024

Advances in Inflammatory Bowel Disease Network

Videos

Becoming a Patient Advocate: Tips for Getting Started

04/12/2024

Featuring Rose Gerber, MS

Patient advocate and cancer survivor Rose Gerber shares her experience in cancer patient advocacy and offers tips for those who wish to become advocates.

Patient advocate and cancer...

04/12/2024

Journal of Clinical Pathways

Thomas Powles, MD, MBBS, Barts Cancer Institute

Videos

Enfortumab Vedotin and Pembrolizumab Among Patients With Advanced Urothelial Cancer in the First-Line Setting

04/11/2024

Featuring Thomas Powles, MBBS, MD

Featuring Thomas Powles, MBBS, MD ...

Thomas Powles, MBBS, MD, discusses results from the phase 3 EV-302 trial, which found enfortumab vedotin plus pembrolizumab improved survival outcomes among patients with previously untreated advanced urothelial carcinoma.

Thomas Powles, MBBS, MD,...

04/11/2024

Oncology